Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation. Cao X, Yang Y, Zhou W, Wang Y, et al. BMC Cancer 2026;26:892.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cao X, Yang Y, Zhou W, Wang Y, et al. Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation. BMC Cancer 2026;26:892.
PMID: 42493786